APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Riboside (NR)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nicotinamide Riboside (NR) Industry Growth and Trends Forecast to 2032

26 December 2025104 pages

Choose your research edition.

Industry ResearchNicotinamide Riboside (NR) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Riboside (NR) Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Nicotinamide Riboside (NR) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Riboside (NR) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Riboside (NR) Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Nicotinamide Riboside (NR) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicotinamide Riboside (NR) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicotinamide Riboside (NR) include ChromaDex, Genex Formulas, Bontac, Tiantai Biotechnology, Zhejiang Jiahua, Shandong Tianming Pharmaceutical, Suzhou MyLand Pharm & Nutrition, EnzymeWorks and Longer Livetech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nicotinamide Riboside (NR) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nicotinamide Riboside (NR) market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nicotinamide Riboside (NR) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nicotinamide Riboside (NR).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nicotinamide Riboside (NR) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nicotinamide Riboside (NR) Market by Company

ChromaDex

Genex Formulas

Bontac

Tiantai Biotechnology

Zhejiang Jiahua

Shandong Tianming Pharmaceutical

Suzhou MyLand Pharm & Nutrition

EnzymeWorks

Longer Livetech

Shenzhen Ejion Biotechnology

Nicotinamide Riboside (NR) Segment by Type

Purity ≤98%

Purity ＞98%

Nicotinamide Riboside (NR) Segment by Application

Health Supplement

Pharmaceutical Additives

Nicotinamide Riboside (NR) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside (NR) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside (NR).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nicotinamide Riboside (NR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity ≤98% Table 2. Major Company of Purity ＞98% Table 3. Global Nicotinamide Riboside (NR) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 5. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Type (2021-2026) Table 8. Global Nicotinamide Riboside (NR) Price by Type (2021-2026) & (US$/Ton) Table 9. Global Nicotinamide Riboside (NR) Sales by Type (2027-2032) & (Tons) Table 10. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nicotinamide Riboside (NR) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Type (2027-2032) Table 13. Global Nicotinamide Riboside (NR) Price by Type (2027-2032) & (US$/Ton) Table 14. North America Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 15. North America Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 17. Europe Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 21. Latin America Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Nicotinamide Riboside (NR) Sales by Type (2021-2026) & (US$ Million) Table 24. Nicotinamide Riboside (NR) Industry Trends Table 25. Nicotinamide Riboside (NR) Industry Drivers Table 26. Nicotinamide Riboside (NR) Industry Opportunities and Challenges Table 27. Nicotinamide Riboside (NR) Industry Restraints Table 28. Global Nicotinamide Riboside (NR) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nicotinamide Riboside (NR) Revenue Market Share by Company (2021-2026) Table 30. Global Nicotinamide Riboside (NR) Sales by Company (2021-2026) & (Tons) Table 31. Global Nicotinamide Riboside (NR) Sales Share by Company (2021-2026) Table 32. Global Nicotinamide Riboside (NR) Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Nicotinamide Riboside (NR) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nicotinamide Riboside (NR) Major Company Production Sites and Headquarters Table 35. Global Nicotinamide Riboside (NR) Company, Product Type & Application Table 36. Global Nicotinamide Riboside (NR) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nicotinamide Riboside (NR) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nicotinamide Riboside (NR) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nicotinamide Riboside (NR) Sales by Region (2021-2026) & (Tons) Table 41. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nicotinamide Riboside (NR) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Region (2021-2026) Table 44. Global Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Nicotinamide Riboside (NR) Sales by Region (2027-2032) & (Tons) Table 46. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nicotinamide Riboside (NR) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Region (2027-2032) Table 49. Global Nicotinamide Riboside (NR) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Nicotinamide Riboside (NR) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 52. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Application (2021-2026) Table 55. Global Nicotinamide Riboside (NR) Price by Application (2021-2026) & (US$/Ton) Table 56. Global Nicotinamide Riboside (NR) Sales by Application (2027-2032) & (Tons) Table 57. Global Nicotinamide Riboside (NR) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nicotinamide Riboside (NR) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nicotinamide Riboside (NR) Sales Market Share in Value by Application (2027-2032) Table 60. Global Nicotinamide Riboside (NR) Price by Application (2027-2032) & (US$/Ton) Table 61. North America Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 62. North America Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 64. Europe Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 68. Latin America Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Nicotinamide Riboside (NR) Sales by Application (2021-2026) & (US$ Million) Table 71. ChromaDex Company Information Table 72. ChromaDex Business Overview Table 73. ChromaDex Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. ChromaDex Nicotinamide Riboside (NR) Product Portfolio Table 75. ChromaDex Recent Development Table 76. Genex Formulas Company Information Table 77. Genex Formulas Business Overview Table 78. Genex Formulas Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Genex Formulas Nicotinamide Riboside (NR) Product Portfolio Table 80. Genex Formulas Recent Development Table 81. Bontac Company Information Table 82. Bontac Business Overview Table 83. Bontac Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Bontac Nicotinamide Riboside (NR) Product Portfolio Table 85. Bontac Recent Development Table 86. Tiantai Biotechnology Company Information Table 87. Tiantai Biotechnology Business Overview Table 88. Tiantai Biotechnology Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio Table 90. Tiantai Biotechnology Recent Development Table 91. Zhejiang Jiahua Company Information Table 92. Zhejiang Jiahua Business Overview Table 93. Zhejiang Jiahua Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio Table 95. Zhejiang Jiahua Recent Development Table 96. Shandong Tianming Pharmaceutical Company Information Table 97. Shandong Tianming Pharmaceutical Business Overview Table 98. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio Table 100. Shandong Tianming Pharmaceutical Recent Development Table 101. Suzhou MyLand Pharm & Nutrition Company Information Table 102. Suzhou MyLand Pharm & Nutrition Business Overview Table 103. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio Table 105. Suzhou MyLand Pharm & Nutrition Recent Development Table 106. EnzymeWorks Company Information Table 107. EnzymeWorks Business Overview Table 108. EnzymeWorks Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio Table 110. EnzymeWorks Recent Development Table 111. Longer Livetech Company Information Table 112. Longer Livetech Business Overview Table 113. Longer Livetech Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Longer Livetech Nicotinamide Riboside (NR) Product Portfolio Table 115. Longer Livetech Recent Development Table 116. Shenzhen Ejion Biotechnology Company Information Table 117. Shenzhen Ejion Biotechnology Business Overview Table 118. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio Table 120. Shenzhen Ejion Biotechnology Recent Development Table 121. North America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. North America Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 123. North America Nicotinamide Riboside (NR) Sales Market Share by Country (2021-2026) Table 124. North America Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032) & (Tons) Table 125. North America Nicotinamide Riboside (NR) Sales Market Share Forecast by Country (2027-2032) Table 126. North America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Nicotinamide Riboside (NR) Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Nicotinamide Riboside (NR) Market Share by Country (2021-2026) Table 129. North America Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Nicotinamide Riboside (NR) Market Share Forecast by Country (2027-2032) Table 131. Europe Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Europe Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 133. Europe Nicotinamide Riboside (NR) Sales Market Share by Country (2021-2026) Table 134. Europe Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032) & (Tons) Table 135. Europe Nicotinamide Riboside (NR) Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Nicotinamide Riboside (NR) Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Nicotinamide Riboside (NR) Market Share by Country (2021-2026) Table 139. Europe Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Nicotinamide Riboside (NR) Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 143. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032) & (Tons) Table 145. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Nicotinamide Riboside (NR) Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Nicotinamide Riboside (NR) Market Share by Country (2021-2026) Table 149. Asia-Pacific Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Nicotinamide Riboside (NR) Market Share Forecast by Country (2027-2032) Table 151. Latin America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Latin America Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 153. Latin America Nicotinamide Riboside (NR) Sales Market Share by Country (2021-2026) Table 154. Latin America Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032) & (Tons) Table 155. Latin America Nicotinamide Riboside (NR) Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Nicotinamide Riboside (NR) Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Nicotinamide Riboside (NR) Market Share by Country (2021-2026) Table 159. Latin America Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Nicotinamide Riboside (NR) Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Nicotinamide Riboside (NR) Sales by Country (2021-2026) & (Tons) Table 163. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032) & (Tons) Table 165. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Nicotinamide Riboside (NR) Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Nicotinamide Riboside (NR) Market Share by Country (2021-2026) Table 169. Middle East and Africa Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Nicotinamide Riboside (NR) Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Nicotinamide Riboside (NR) Distributors List Table 174. Nicotinamide Riboside (NR) Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Nicotinamide Riboside (NR) Image Figure 2. Global Nicotinamide Riboside (NR) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Riboside (NR) Market Size (2021-2032) & (US$ Million) Figure 4. Global Nicotinamide Riboside (NR) Sales (2021-2032) & (Tons) Figure 5. Purity ≤98% Image Figure 6. Global Purity ≤98% Sales YoY Growth (2021-2032) & (Tons) Figure 7. Purity ＞98% Image Figure 8. Global Purity ＞98% Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Nicotinamide Riboside (NR) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nicotinamide Riboside (NR) Market Share by Type 2025 VS 2032 Figure 11. North America Nicotinamide Riboside (NR) Sales Market Share in Volume by Type in 2025 Figure 12. North America Nicotinamide Riboside (NR) Sales Market Share in Value by Type in 2025 Figure 13. Europe Nicotinamide Riboside (NR) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nicotinamide Riboside (NR) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nicotinamide Riboside (NR) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nicotinamide Riboside (NR) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nicotinamide Riboside (NR) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Health Supplement Image Figure 24. Global Health Supplement Sales YoY Growth (2021-2032) & (Tons) Figure 25. Pharmaceutical Additives Image Figure 26. Global Pharmaceutical Additives Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Nicotinamide Riboside (NR) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Nicotinamide Riboside (NR) Market Share by Application 2025 VS 2032 Figure 29. North America Nicotinamide Riboside (NR) Sales Market Share in Volume by Application in 2025 Figure 30. North America Nicotinamide Riboside (NR) Sales Market Share in Value by Application in 2025 Figure 31. Europe Nicotinamide Riboside (NR) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Nicotinamide Riboside (NR) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Nicotinamide Riboside (NR) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Nicotinamide Riboside (NR) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Nicotinamide Riboside (NR) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Nicotinamide Riboside (NR) Sales Market Share in Value by Application in 2025 Figure 39. North America Nicotinamide Riboside (NR) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Nicotinamide Riboside (NR) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Nicotinamide Riboside (NR) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Nicotinamide Riboside (NR) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Nicotinamide Riboside (NR) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Nicotinamide Riboside (NR) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nicotinamide Riboside (NR) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Nicotinamide Riboside (NR) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Nicotinamide Riboside (NR) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Nicotinamide Riboside (NR) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nicotinamide Riboside (NR) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Nicotinamide Riboside (NR) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Nicotinamide Riboside (NR) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Nicotinamide Riboside (NR) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nicotinamide Riboside (NR) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Nicotinamide Riboside (NR) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Nicotinamide Riboside (NR) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Nicotinamide Riboside (NR) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nicotinamide Riboside (NR) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Nicotinamide Riboside (NR) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Nicotinamide Riboside (NR) Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Nicotinamide Riboside (NR) Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≤98%
  • Purity ＞98%
Applications
  • Health Supplement
  • Pharmaceutical Additives
Companies covered
  • ChromaDex
  • Genex Formulas
  • Bontac
  • Tiantai Biotechnology
  • Zhejiang Jiahua
  • Shandong Tianming Pharmaceutical
  • Suzhou MyLand Pharm & Nutrition
  • EnzymeWorks
  • Longer Livetech
  • Shenzhen Ejion Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinamide Riboside (NR) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nicotinamide Riboside (NR) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nicotinamide Riboside (NR) Market by Type
  6. 1.3.1 Purity ≤98%
  7. 1.3.2 Purity ＞98%
  8. 1.4 Global Nicotinamide Riboside (NR) Market Size by Type
  9. 1.4.1 Global Nicotinamide Riboside (NR) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nicotinamide Riboside (NR) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nicotinamide Riboside (NR) Industry Trends
  2. 2.2 Nicotinamide Riboside (NR) Industry Drivers
  3. 2.3 Nicotinamide Riboside (NR) Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Riboside (NR) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nicotinamide Riboside (NR) Revenue (2021-2026)
  2. 3.2 Global Top Players by Nicotinamide Riboside (NR) Sales (2021-2026)
  3. 3.3 Global Top Players by Nicotinamide Riboside (NR) Price (2021-2026)
  4. 3.4 Global Nicotinamide Riboside (NR) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicotinamide Riboside (NR) Major Company Production Sites & Headquarters
  6. 3.6 Global Nicotinamide Riboside (NR) Company, Product Type & Application
  7. 3.7 Global Nicotinamide Riboside (NR) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicotinamide Riboside (NR) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicotinamide Riboside (NR) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nicotinamide Riboside (NR) Tier 1, Tier 2, and Tier 3
4 Nicotinamide Riboside (NR) Regional Status and Outlook
  1. 4.1 Global Nicotinamide Riboside (NR) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nicotinamide Riboside (NR) Historic Market Size by Region
  3. 4.2.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Region
  7. 4.3.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nicotinamide Riboside (NR) by Application
  1. 5.1 Nicotinamide Riboside (NR) Market by Application
  2. 5.1.1 Health Supplement
  3. 5.1.2 Pharmaceutical Additives
  4. 5.2 Global Nicotinamide Riboside (NR) Market Size by Application
  5. 5.2.1 Global Nicotinamide Riboside (NR) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Nicotinamide Riboside (NR) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ChromaDex
  2. 6.1.1 ChromaDex Company Information
  3. 6.1.2 ChromaDex Business Overview
  4. 6.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ChromaDex Nicotinamide Riboside (NR) Product Portfolio
  6. 6.1.5 ChromaDex Recent Developments
  7. 6.2 Genex Formulas
  8. 6.2.1 Genex Formulas Company Information
  9. 6.2.2 Genex Formulas Business Overview
  10. 6.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Genex Formulas Nicotinamide Riboside (NR) Product Portfolio
  12. 6.2.5 Genex Formulas Recent Developments
  13. 6.3 Bontac
  14. 6.3.1 Bontac Company Information
  15. 6.3.2 Bontac Business Overview
  16. 6.3.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bontac Nicotinamide Riboside (NR) Product Portfolio
  18. 6.3.5 Bontac Recent Developments
  19. 6.4 Tiantai Biotechnology
  20. 6.4.1 Tiantai Biotechnology Company Information
  21. 6.4.2 Tiantai Biotechnology Business Overview
  22. 6.4.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Product Portfolio
  24. 6.4.5 Tiantai Biotechnology Recent Developments
  25. 6.5 Zhejiang Jiahua
  26. 6.5.1 Zhejiang Jiahua Company Information
  27. 6.5.2 Zhejiang Jiahua Business Overview
  28. 6.5.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Product Portfolio
  30. 6.5.5 Zhejiang Jiahua Recent Developments
  31. 6.6 Shandong Tianming Pharmaceutical
  32. 6.6.1 Shandong Tianming Pharmaceutical Company Information
  33. 6.6.2 Shandong Tianming Pharmaceutical Business Overview
  34. 6.6.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Product Portfolio
  36. 6.6.5 Shandong Tianming Pharmaceutical Recent Developments
  37. 6.7 Suzhou MyLand Pharm & Nutrition
  38. 6.7.1 Suzhou MyLand Pharm & Nutrition Company Information
  39. 6.7.2 Suzhou MyLand Pharm & Nutrition Business Overview
  40. 6.7.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Product Portfolio
  42. 6.7.5 Suzhou MyLand Pharm & Nutrition Recent Developments
  43. 6.8 EnzymeWorks
  44. 6.8.1 EnzymeWorks Company Information
  45. 6.8.2 EnzymeWorks Business Overview
  46. 6.8.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 EnzymeWorks Nicotinamide Riboside (NR) Product Portfolio
  48. 6.8.5 EnzymeWorks Recent Developments
  49. 6.9 Longer Livetech
  50. 6.9.1 Longer Livetech Company Information
  51. 6.9.2 Longer Livetech Business Overview
  52. 6.9.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Longer Livetech Nicotinamide Riboside (NR) Product Portfolio
  54. 6.9.5 Longer Livetech Recent Developments
  55. 6.10 Shenzhen Ejion Biotechnology
  56. 6.10.1 Shenzhen Ejion Biotechnology Company Information
  57. 6.10.2 Shenzhen Ejion Biotechnology Business Overview
  58. 6.10.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Product Portfolio
  60. 6.10.5 Shenzhen Ejion Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America Nicotinamide Riboside (NR) Sales by Country
  2. 7.1.1 North America Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nicotinamide Riboside (NR) Sales by Country (2021-2026)
  4. 7.1.3 North America Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nicotinamide Riboside (NR) Market Size by Country
  6. 7.2.1 North America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nicotinamide Riboside (NR) Market Size by Country (2021-2026)
  8. 7.2.3 North America Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nicotinamide Riboside (NR) Sales by Country
  2. 8.1.1 Europe Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nicotinamide Riboside (NR) Sales by Country (2021-2026)
  4. 8.1.3 Europe Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nicotinamide Riboside (NR) Market Size by Country
  6. 8.2.1 Europe Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nicotinamide Riboside (NR) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nicotinamide Riboside (NR) Sales by Country
  2. 9.1.1 Asia-Pacific Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nicotinamide Riboside (NR) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nicotinamide Riboside (NR) Market Size by Country
  6. 9.2.1 Asia-Pacific Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nicotinamide Riboside (NR) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nicotinamide Riboside (NR) Sales by Country
  2. 10.1.1 South America Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nicotinamide Riboside (NR) Sales by Country (2021-2026)
  4. 10.1.3 South America Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nicotinamide Riboside (NR) Market Size by Country
  6. 10.2.1 South America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nicotinamide Riboside (NR) Market Size by Country (2021-2026)
  8. 10.2.3 South America Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nicotinamide Riboside (NR) Sales by Country
  2. 11.1.1 Middle East and Africa Nicotinamide Riboside (NR) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nicotinamide Riboside (NR) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nicotinamide Riboside (NR) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nicotinamide Riboside (NR) Market Size by Country
  6. 11.2.1 Middle East and Africa Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nicotinamide Riboside (NR) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nicotinamide Riboside (NR) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nicotinamide Riboside (NR) Value Chain Analysis
  2. 12.1.1 Nicotinamide Riboside (NR) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nicotinamide Riboside (NR) Production Mode & Process
  7. 12.2 Nicotinamide Riboside (NR) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nicotinamide Riboside (NR) Distributors
  10. 12.2.3 Nicotinamide Riboside (NR) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst